Clinical Trials & Medical Discoveries The most recent news and results from scientific and medical research, including testing, diagnosis, and treatment. Stay up-to-date on the latest medical discoveries and breakthroughs with announcements of new products to be tested, upcoming clinical trials and studies and newly published results. Also included are updates regarding funding decisions, company performance, and legal news.

Latest

15 Apr, 2019, 09:00 BST Norgine: New Real World Study Shows Rifaximin-a Significantly Reduced Hospitalisation in Patients With Overt Hepatic Encephalopathy (HE) When Added to Lactulose

Norgine B.V. today highlighted results of a real world study showing significant reductions in the number and length of hospitalisations when...


11 Apr, 2019, 19:12 BST InDex Pharmaceuticals Provides Status Update on the Patient Recruitment in the CONDUCT Study

InDex Pharmaceuticals Holding AB (publ) today announced that 197 patients, of the total 215 planned, have been enrolled to date in the CONDUCT study...


11 Apr, 2019, 13:30 BST Why International Regulations on Clinical Trials can Actually Reduce Costs and Shorten Time to Market

Every business or industry strives to improve quality, reduce costs and improve their products time to market. This, surprisingly, is true for the...


11 Apr, 2019, 12:49 BST LumiThera Announces First Patient Enrollment in the European Multi-Center, LIGHTSITE II Clinical Study to Treat Dry Age-Related Macular Degeneration

LumiThera Inc., a commercial stage medical device company delivering photobiomodulation (PBM) treatment for ocular disorders and disease, today...


11 Apr, 2019, 12:00 BST Completion of the First Interventional Phase-II Trial in the Innovative Medicines Initiative's New Drugs 4 Bad Bugs Programme

The Innovative Medicines Initiative (IMI)-funded COMBACTE-NET (Combatting Bacterial Resistance in Europe) consortium has completed the SAATELLITE...


11 Apr, 2019, 08:00 BST GenePOC Obtains CE Marked for Its GenePOC™ Carba Test

GenePOC Inc., member of the Debiopharm Group, announces its third test to be CE marked, the GenePOC Carba assay, to be used with the revogene™ device....


10 Apr, 2019, 09:53 BST Alligator Bioscience to Present New Preclinical Data on ATOR-1015 at PEGS Boston

Alligator Bioscience (Nasdaq Stockholm: ATORX), today announces that Chief Medical Officer Charlotte Russell, MD, PhD, will give an oral presentation ...


10 Apr, 2019, 08:50 BST New study exposes need for better management of anaemia

A large study just published in the journal Anaesthesia raises important questions about the way anaemia is currently managed in surgical patients...


10 Apr, 2019, 06:24 BST Nordic Nanovector: Safety Review Committee Approves Advancing to Final Dosing Regimen in Phase 1 Trial of Betalutin® in DLBCL

Nordic Nanovector ASA (OSE: NANO) announces that the Safety Review Committee (SRC) for the ongoing LYMRIT 37-05 clinical trial of...


09 Apr, 2019, 16:35 BST Through Pioneering Clinical Research, Institute of Life IVF Center in Greece and Embryotools in Spain Achieve Global Innovation in Assisted Reproduction

The birth of the first healthy baby through the pioneering Maternal Spindle Transfer method – implemented for the first time by the Institute of Life ...


09 Apr, 2019, 13:30 BST Biotech Brief: Growing Number of Ongoing Clinical Trials for Leukemia (AML) Brings New Hope

In the last few years the number of clinical trials looking for new treatments for Leukemia (AML) has continued to grow. In 2017, a report from...


09 Apr, 2019, 12:00 BST Alkermes Announces Positive Topline Results From Innovative Study of ARISTADA® and INVEGA SUSTENNA® for the Treatment of Schizophrenia

Alkermes plc (Nasdaq: ALKS) today announced positive topline results from ALPINE (Aripiprazole Lauroxil and Paliperidone palmitate: INitiation...


09 Apr, 2019, 09:02 BST Alvogen and Business Partners Obtain First European Approvals for Generic Ulipristal 5mg

Alvogen today announced that it has successfully concluded sixteen parallel registration procedures for Ulipristal tablets. Alvogen and its business...


09 Apr, 2019, 09:00 BST Enesi Pharma and University of Oxford Collaborate to Target Plague With a Novel ImplaVax®-enabled Adenovirus-based Solid Dose Vaccine

Enesi Pharma ("Enesi"), an innovative pharmaceutical company developing unique injectable solid dose drug-device vaccine products and scientists at...


09 Apr, 2019, 06:00 BST Pharming Group Announces Completion of Minority Investment in BioConnection BV

Highlights: Pharming takes a significant minority stake in BioConnection BV, its world class fill & finish partner Pharming has acquired its...


08 Apr, 2019, 12:15 BST The Brain Protection Company Announces Publication Of Manuscript By European Heart Journal Showing Carotid Pulse Intensity Powerfully Predicts Cognitive Decline

The Brain Protection Company Pty Ltd, a privately-held medical device company developing novel therapies and diagnostics for age-related...


08 Apr, 2019, 10:02 BST Clinical Trial Investigates Orbsen Therapeutics' ORBCEL-C™ Immunotherapy as Treatment for Two Autoimmune Liver Diseases

Orbsen Therapeutics, a biotechnology company focused on the development and commercialization of first-in-class stromal cell immunotherapies,...


08 Apr, 2019, 09:00 BST Galderma Marks Rosacea Awareness Month With New Insights Into Why Some Patients Are Self-treating and Launches Social Media Campaign to Reinforce Hidden Impact of the Disease

Building on the expert-authored report Rosacea: Beyond the visible, which highlighted the true extent of the psychosocial burden of rosacea globally, ...


06 Apr, 2019, 18:08 BST Positive Treatment Results for Buvidal® in Fentanyl Users Presented at the ASAM 50th Annual Conference

Camurus announces positive post-hoc analyses results from the randomized, double-blind, double-dummy Phase 3 study of CAM2038 (Buvidal®,...


05 Apr, 2019, 07:00 BST Mallinckrodt Announces Study Demonstrating Effectiveness of ECP Immunomodulation, as an adjunct to local standard therapy, in Treatment of Lung Transplant Patients with Bronchiolitis Obliterans Syndrome (BOS)

Mallinckrodt plc (NYSE: MNK), a leading specialty pharmaceutical company, announces the presentation of a retrospective study that demonstrates the...


04 Apr, 2019, 13:24 BST Norgine New Study Highlights Need to Increase Public Understanding of Important Role of Colonoscopy in Preventing and Diagnosing Gastrointestinal Diseases, Including Colorectal Cancer

NORGINE B.V. (Norgine) today published the findings of a public survey at the European Society of Gastrointestinal Endoscopy (ESGE) Days in Prague as ...


04 Apr, 2019, 08:00 BST Enteromed Conducts New Clinical Research into Irritable Bowel Syndrome that can Offer Real Hope and Drug Free Relief to Patients

A large clinical trial "RELIEVE-IBS-D" for patients with diarrhoea predominant IBS (IBS-D) included in the National Institute for Health Research...


03 Apr, 2019, 13:03 BST EMA Validates Daiichi Sankyo's Marketing Authorization Application for Pexidartinib for Treatment of Patients with TGCT, a Rare, Debilitating, Non-Malignant Tumor

Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) announced that the European Medicines Agency (EMA) validated the Marketing Authorization...


02 Apr, 2019, 12:42 BST Alligator Bioscience: New Preclinical Data for ATOR-1144 Demonstrate Potential for Activation of Both the Innate and the Adaptive Immune System, as well as Direct Anti-tumor Effects

Alligator Bioscience (Nasdaq Stockholm: ATORX), today announce that new preclinical data on the drug candidate ATOR-1144 will be presented at the...


02 Apr, 2019, 12:00 BST Sangamo and Pfizer Announce Phase 1/2 Interim Data For Investigational Hemophilia A Gene Therapy

Sangamo Therapeutics, Inc. (NASDAQ: SGMO), a genomic medicine company, and Pfizer, Inc. (NYSE: PFE) today announced interim data from the Phase 1/2...